What is the main indication for Dipyridamole?

Dipyridamole is primarily indicated for its antiplatelet effects, which are crucial in reducing the risk of stroke, especially in patients who have had transient ischemic attacks or certain types of heart surgery. It works by inhibiting the uptake of adenosine and increasing its availability, which results in vasodilation and reduced platelet aggregation.

The primary focus of dipyridamole therapy is in the realm of cardiology and stroke prevention rather than treatment options associated with pain management or hypertension. While angina, chronic pain, and hypertension are significant health concerns, they are not the primary conditions for which dipyridamole is prescribed. Thus, its main role in clinical practice is in the context of reducing stroke risk, particularly following specific cardiovascular events.